Home > National Drug Code (NDC) > Losartan Potassium and Hydrochlorothiazide

Losartan Potassium and Hydrochlorothiazide - 52125-399-19 - (Losartan Potassium and Hydrochlorothiazide)

Alphabetical Index


Drug Information of Losartan Potassium and Hydrochlorothiazide

Product NDC: 52125-399
Proprietary Name: Losartan Potassium and Hydrochlorothiazide
Non Proprietary Name: Losartan Potassium and Hydrochlorothiazide
Active Ingredient(s): 25; 100    mg/1; mg/1 & nbsp;   Losartan Potassium and Hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Losartan Potassium and Hydrochlorothiazide

Product NDC: 52125-399
Labeler Name: REMEDYREPACK INC.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA090528
Marketing Category: ANDA
Start Marketing Date: 20130514

Package Information of Losartan Potassium and Hydrochlorothiazide

Package NDC: 52125-399-19
Package Description: 90 TABLET in 1 VIAL (52125-399-19)

NDC Information of Losartan Potassium and Hydrochlorothiazide

NDC Code 52125-399-19
Proprietary Name Losartan Potassium and Hydrochlorothiazide
Package Description 90 TABLET in 1 VIAL (52125-399-19)
Product NDC 52125-399
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Losartan Potassium and Hydrochlorothiazide
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20130514
Marketing Category Name ANDA
Labeler Name REMEDYREPACK INC.
Substance Name HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
Strength Number 25; 100
Strength Unit mg/1; mg/1
Pharmaceutical Classes Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]

Complete Information of Losartan Potassium and Hydrochlorothiazide


General Information